financetom
Business
financetom
/
Business
/
Ares Management to Acquire Minority Stake in EP Wealth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ares Management to Acquire Minority Stake in EP Wealth
Sep 30, 2025 9:22 AM

11:53 AM EDT, 09/30/2025 (MT Newswires) -- Ares Management ( ARES ) Private Equity funds has signed an agreement to acquire a "significant" minority stake in EP Wealth Advisors, the investment advisory firm said Tuesday.

Ares' investment will provide EP Wealth with capital and strategic support for its corporate initiatives, including talent acquisition, technology, and client-facing offerings, according to the company.

EP Wealth said its management will continue to operate independently.

The deal is expected to be completed in October. Terms were not disclosed, according to a statement.

Ares shares fell 4% in recent trading.

Price: 156.96, Change: -6.46, Percent Change: -3.96

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TeamViewer Agrees To Acquire Carlyle-Backed 1E For $720 Million: Details
TeamViewer Agrees To Acquire Carlyle-Backed 1E For $720 Million: Details
Dec 11, 2024
TeamViewer has entered an agreement with Carlyle Europe Technology Partners (CETP), part of the global investment firm Carlyle Group ( CG ) , to acquire 1E, a Digital Employee Experience (DEX) management tools company, for $720 million in a cash-free, debt-free deal. 1E, with around 300 employees, offers a leading DEX platform that boosts IT performance and employee satisfaction through...
Satellos Doses First Participant with Duchenne Muscular Dystrophy in Phase 1b Trial
Satellos Doses First Participant with Duchenne Muscular Dystrophy in Phase 1b Trial
Dec 11, 2024
07:55 AM EST, 12/11/2024 (MT Newswires) -- Satellos Bioscience ( MSCLF ) (MSCL.TO on Wednesday said that the first participant with Duchenne muscular dystrophy (DMD) has been dosed in the phase 1b safety and pharmacokinetics trial in DMD patients. The company expects to enroll up to 10 adult participants with genetically confirmed DMD in a 28-day, open-label, single dose cohort....
Commerzbank Sees Bank of Canada Cutting Rates by 50bps Wednesday; Comments on The Currency
Commerzbank Sees Bank of Canada Cutting Rates by 50bps Wednesday; Comments on The Currency
Dec 11, 2024
07:55 AM EST, 12/11/2024 (MT Newswires) -- In line with the consensus, Commerzbank said it expects the Bank of Canada to cut interest rates another time by 50 basis points Wednesday to 3.25%. Canada's central bank is slated to release its policy statement at 9:45 a.m. ET Wednesday. The rate reduction estimate isn't only supported by the weak labor market,...
Relay Therapeutics Says RLY-2608 With Fulvestrant Data Shows 'Clinically Meaninful' Metastatic Breast Cancer Survival
Relay Therapeutics Says RLY-2608 With Fulvestrant Data Shows 'Clinically Meaninful' Metastatic Breast Cancer Survival
Dec 11, 2024
07:58 AM EST, 12/11/2024 (MT Newswires) -- Relay Therapeutics ( RLAY ) said Wednesday updated interim clinical data from its first-in-human study of RLY-2608 in combination with fulvestrant showed clinically meaningful progression-free survival in patients with locally advanced or metastatic breast cancer. The updated data showed a median progression-free survival of 11.4 months in second-line patients who received a 600-milligram...
Copyright 2023-2026 - www.financetom.com All Rights Reserved